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 The prognostic value of individual depressive symptoms is heterogeneous
 Negative self-image and indecisiveness predicted mortality in men 
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 Dissatisfaction and fatigue predicted mortality in men ≥70 years
 None of the symptoms predicted mortality in women ≤55 years
Abstract
Background: Depression predicts poor prognosis in patients with myocardial infarction (MI). However, 
individual depressive symptoms may have different prognostic value, and age and sex could be important 
effect modifiers. This study compared the prognostic value of individual depressive symptoms across age 
and sex subgroups in post-MI patients.
Methods: Individual patient-data were compiled for 6,673 post-MI patients from seven studies. Depressive 
symptoms were measured with 10 items of the Beck Depression Inventory (BDI10). The endpoint was all-
cause mortality (mean=3.8 years). Multilevel multivariable Cox regression analysis was used to estimate 
the mortality risk across age groups (≤55, 56-69 and ≥70 years) and sex for symptoms that potentially 
interacted with age and sex.
Results: At follow-up, 995 (15%) post-MI patients had died. BDI10 depression scores were associated with 
an increased mortality risk (HR:1.20;95%CI:1.11-1.28,p<.001). Negative self-image (HR:1.53;1.06-
2.21;p=.022) and indecisiveness (HR:1.53;1.15-2.04;p=.003) were associated with increased mortality in 
men <55. Dissatisfaction was associated with increased mortality in men aged 56-69 (HR:1.35;1.07-
1.71;p=. 011), and dissatisfaction (HR:1.34;1.10-1.63;p=.003) and fatigue (HR:1.45;1.20-1.74;p<.001) in 
men >70. Fatigue was associated with mortality in women aged 56-69 (HR:1.54;1.09-2.15;p=.012), and 
suicidal ideation in women aged >70 (HR:1.58;1.03-2.43;p=.037). Left-ventricular ejection fraction 
(LVEF) accounted for much of the associations in men ≤55 years and women ≥70 years.
Limitations:, Findings are sample-specific and need replication in future research; BDI10 items were 
derived from the original BDI assessment. 
Conclusions: There is large heterogeneity in the prognostic value of individual depressive symptoms in 
post-MI patients across sex and age subgroups. LVEF partially explained the depression-prognosis 
association in specific subgroups.
1Introduction
Depression has been associated with poor prognosis in patients with myocardial infarction (MI) (Meijer et al. 
2013). However, depression is a heterogeneous syndrome, and major depressive disorder is a polythetic diagnostic 
category (Østergaard, Jensen & Bech 2011). An analysis of a sample of patients who met the DSM-V criteria for major 
depression identified 1030 different symptom profiles (Fried, Nesse 2015).
The analysis of individual depression symptoms may offer a way forward to better understand the complex 
nature of depression and its consequences (Fried 2017, Fried, Nesse 2015), including the adverse effect of specific 
depression symptoms on cardiac prognosis. An unresolved issue is the degree to which individual symptoms of 
depression may be differentially related to cardiovascular disease outcomes. Therefore, a solution authors found for 
addressing this heterogeneity was to use symptom dimensions such as a cognitive/affective dimension (e.g. guilt, sense 
of failure, self-punishment) and a somatic/affective dimension (e.g. work difficulties, insomnia, fatigue) to predict 
cardiovascular outcomes (de Miranda Azevedo et al. 2014). Another, more in-depth, approach to address the 
heterogeneity of depressive symptoms is individual item-level analysis, in which the prognostic value of each 
depressive symptom is evaluated (Denollet et al. 2013). Moreover, specific depressive symptoms may refer to distinct 
phenomena that differ from each other in important dimensions, including biology, risk factors, and impact on 
impairment and prognosis (Fried, Nesse 2015). 
Another unresolved issue is whether age modifies the prognostic value of depressive symptoms in patients 
with MI(Denollet et al. 2013). Age is an important determinant of medical prognosis in patients with MI(Kral et al. 
2011) and therefore statistical adjustment for age is commonly seen in prognostic studies. A previous study suggested 
that cognitive/affective symptoms are especially deleterious in younger patients with MI(Denollet et al. 2013). 
However, few of the previous analyses have been stratified by age, leaving no possibility to investigate whether the 
prognostic effect of depression is age-dependent (Gupta et al. 2014). In terms of clinical profile, older patients are more 
likely to have greater comorbidity, increased cardiac dysfunction, history of previous MI, left-ventricular ejection 
fraction (LVEF) ≤ 40%, and Killip class >1 as compared with younger patients(Shih et al. 2010). Regarding lifestyle 
factors, younger patients may display a worse risk profile as compared with older patients(Egred, Viswanathan & Davis 
2005).
Sex also appears to modify the association between depression and medical prognosis of patients with MI. On 
average, women have their first MI at an older age, have more comorbidities and stay longer hospitalized than 
men(Gupta et al. 2014). Also, the incidence of post-MI mortality is higher among women than men(Pancholy et al. 
2014, Hanratty et al. 2000). Meta-analysis of individual-participant data (IPD) from 16 studies suggests that depression 
2is associated with adverse prognosis in men but not in women (Doyle et al. 2015), but other studies have found the 
opposite or no difference(Shah et al. 2014). Moreover, the prevalence of symptoms of depression is higher in women 
than in men(Martin LA, Neighbors HW,Griffith DM 2013). Hence, more research is needed to investigate whether any 
potential sex differences in the predictive power of depression may depend on the symptoms reported.
The objective of this study is to investigate possible interactions among age, sex, and individual depressive 
symptoms in relation to all-cause mortality following acute MI. 
Methods
Patients
A systematic search of the Medline, EMBASE and PsycINFO databases was conducted to identify intervention 
and prognostic studies published prior to January 5, 2011. Studies were included if they had analyzed the association 
between depression and cardiovascular prognosis in post-MI patients. More information on this systematic search is 
available elsewhere (Meijer et al. 2013). Information on individual studies characteristics is presented in Table 1.
Endpoint
The primary endpoint of the present study was all-cause mortality. On average, a follow up time of 3.8 ± 2.5 
years (median = 2.28; interquartile range = 3.67) for all-cause mortality was recorded.
Symptoms of depression
We selected studies in post-MI patients that included depressive symptoms as measured by the Beck 
Depression Inventory (BDI) and that included time-to-event data. 
The BDI (Beck, Steer 1987) is a 21-item questionnaire that is often used in studies of patients with MI, but 
several shorter versions exist (Furlanetto, Mendlowicz & Romildo Bueno 2005, Denollet et al. 2010). In the present 
study, we used 10 items of the BDI that compose a shorter version of the BDI: the BDI10. The BDI10 is designed to 
assess 10 symptoms in cardiac patients across three dimensions of: core symptoms (sadness and hopelessness); negative 
self-view (sense of failure, self- dislike, suicidal ideation and negative self-image), and lack of satisfaction/energy 
(dissatisfaction, indecisiveness, work inhibition and fatigue). Denollet and colleagues suggested that the 4th response 
category (the most severe form of each symptom) is seldom checked by patients with MI. Therefore only three response 
categories were used, by merging the 3rd and 4th response categories. 
3Clinical covariates
We included in the combined dataset clinical and lifestyle covariates that are related to medical prognosis in 
patients with MI. History of prior MI was used as a marker of heart disease severity. Data on aspirin and beta-blocker 
use were available in all individual studies, and were included to control for medication use in the present study. 
Diabetes was included as a covariate to represent comorbidity and smoking as an unhealthy lifestyle factor. These 
covariates were selected because they were generally available in all included studies, and a number of individual 
studies had no data on left-ventricular ejection fraction (LVEF), statins, or platelet inhibitors. Because LVEF is 
associated with poor prognosis in patients with MI (Doyle et al. 2015), we also used this covariate in sensitivity 
analyses in the subset of studies that included LVEF.
Statistical analysis
Risks for all-cause mortality were estimated with multivariable mixed-effects Cox proportional hazards 
models. Since data were multi-level, between-study heterogeneity was accounted by modeling the study level as a 
random intercept. Since there was low between-study variation, a random slope was not included. Since between-study 
heterogeneity between individual studies was low (Q-value = 8.297 (6); p = 0.217; I2= 28%) a random slope was not 
included. The assumption of proportionality of hazards for the Cox proportional hazards models was checked, by 
including time-dependent covariates in the models. A statistically significant time-dependent covariate (p < .05) is 
indicative of violation of the assumption.
To assess how age and sex modifies the association of depressive symptoms in predicting all-cause mortality, 
the following steps were taken. First (step 1a), we built multivariable models including three-way interaction terms (i.e. 
Age X Sex X BDI10 individual item) and clinical covariates (history of MI, aspirin use, beta blocker use, smoking and 
diabetes). A model assessing the three-way interaction between the BDI10 sum score was also built. Step 1b consisted 
of stratifying the sample according to sex and age groups, and to conduct multivariable subgroup analyses for 
symptoms that potentially interacted with age and sex simultaneously. In step 2a the same procedure was repeated for 
the symptoms that did not indicate a three-way interaction. Instead, two-way interaction terms were used in separate 
models (Age X BDI10; Sex X BDI10). Afterwards, in step 2b, subgroup analyses were conducted for symptoms that 
potentially interacted either with age or sex. The same procedure was conducted for the BDI10 sum score. To evaluate 
the internal consistency of the BDI10, Crohnbach’s α was computed.
Because the association between depression and cardiovascular-related variables is often curvilinear, we also 
explored the possibility of curvilinear relationships by adding quadratic terms for age to the models. When the quadratic 
4term did not reach statistical significance, a linear term was investigated. Three age subgroups were evaluated: 55 years 
or younger, from 56 to 69 years and 70 years or older. These age categories were defined according to a previously 
published prognostic study (Gupta et al. 2014). Sex stratification was performed within the age groups for three-way 
interaction and separately for two-way interaction assessment.
Since between-study heterogeneity between individual studies was low (Q-value = 8.297 (6); p = 0.217; I2= 
28%) a random slope was not included. Following previous recommendations, a confidence level of α=.20 was used 
when screening for interactions (Selvin 1996) in steps 1a and 2a. For main effects in subgroup analyses, a confidence 
level of α=.05 was used. All the analyses were conducted using Stata 13.0.
Sensitivity analyses
Due to the considerable shared variance among depressive symptoms, additional sensitivity analyses were 
conducted by including statistical adjustment for the remaining depressive symptoms (additionally to the other 
covariates already included in the main models).  
Assessment for LVEF was not included in two of the studies composing the total sample(Lauzon et al. 2003, 
Lane et al. 2001). Therefore, we also conducted sensitivity analyses adjusting for LVEF (additionally to the other 
covariates already included in the main models) for symptoms that potentially interacted with age and sex in three-way 
and two-way interaction models in the subsample that included assessment for LVEF. 
Missing data
As third parties provided the datasets used in the present study, missing data could not always be retrieved. A 
substantial part of the sample had imputed missing data on individual BDI items using the average of the available 
participants’ symptoms (27%). Therefore, we did use the same technique for imputing missing data on the rest of the 
sample. Participants with more than six missing items on the BDI were excluded from the analyses. For other variables, 
data was missing in very few cases such as history of MI (1.24%); aspirin use (3.10%); beta-blocker use (2.79%) and 
smoking (2.08%).
Results
Age, sex and clinical characteristics
A total of 2,276 (36%) participants were aged ≤55 years, 2,448 (38%) were aged between 56-69 years and 
1,639 (26%) were aged 70 years or more. The analogous figures for men in these age groups were: 1,738 (76%), 1,819 
(71%) and 1,025 (57%), respectively. In the group aged ≥70 years, 1,025 were men (57%). More information on 
5individual studies and the combined sample characteristics is available in Table 1.
(TABLE 1 HERE)
Depressive symptoms as measured by the BDI10
The internal consistency of the depressive symptoms as calculated by the BDI10 was 0.83 in the present 
sample. The internal consistency did not improve by removing any of the items. Item-rest correlation coefficients were 
higher than 0.4 for all individual items except for the item “suicidal ideation”, suggesting that all items correlated 
sufficiently with the total sum score. The median of the BDI10 score was 4, and the interquartile range was 6. The most 
reported item of the BDI10 was fatigue (74% of the participants), followed by work difficulties (63%). Suicidal 
ideation was the least reported item (7%). Individual BDI10 items response frequencies, reliability, and item-rest 
correlation coefficients are presented in Table 2. 
(TABLE 2 HERE)
All-cause mortality
After a mean follow-up of 3.8 years (median = 2.28; interquartile range = 3.67), 995 (15%) post-MI patients 
had died. The assumption of proportionality of hazards was met for all variables. Higher levels of depressive symptoms 
as measured by the BDI10 sum score were associated with an increased risk of all-cause mortality (HR: 1.20; 1.11 – 
1.28, p < .001) in the total sample.
All the covariates were significantly associated with all-cause mortality in univariable models 
(Supplementary material 1). Unexpectedly, smoking was negatively associated with all-cause mortality, suggesting a 
protective effect. After running this same analysis while adjusting for age, the association between smoking and all-
cause mortality became positive, suggesting that the association between smoking and all-cause mortality was 
confounded by age (results not shown). In the present sample, most participants smoking were younger than 55 years. 
Therefore, the younger age of the smokers could have acted as a confounder in the relationship between smoking and 
mortality.
Multilevel multivariable proportional hazards models of mortality
Three-way interaction terms with mortality
The three-way interaction term between age, sex and BDI10 sum score in the multivariable model was not 
6significant (95% CI 0.99 – 1.02; p = .579. Results for the three-way interaction terms across individual items are 
presented in the Supplementary material 2. A potential significant quadratic term for age was found only for suicidal 
ideation. Potential interaction terms with p-values ≤ .20 were found for suicidal ideation (95% CI 0.99 – 1.00; (p = 
.065), negative self-image (95% CI 0.96 – 1.00; p = .127), dissatisfaction (95% CI 0.99 – 1.03; p = .170), indecisiveness 
(95% CI 0.97 – 1.00; p  = .145) and fatigue (95% CI 1.00 – 1.04; p = .020).
Subgroup analyses of mortality according to both age and sex
When a potential interaction between an item of the BDI10, age and sex was identified (i.e. p ≤ .20), we 
performed subgroup analyses assessing the risk of all-cause mortality associated with these symptoms across age and 
sex groups (Table 3). In women aged between 56 and 69 years, fatigue was associated with mortality (HR: 1.54; 95% 
CI 1.09-2.15). In women 70 years or older, suicidal ideation was associated with mortality (HR: 1.58; 95% CI 1.03-
2.43). In men, dissatisfaction was associated with mortality in both the 56-69 year (HR: 1.35; 95% CI 1.07-1.71) and 
≥70 year (HR: 1.34; 95% CI 1.10-1.63) age groups, but not in the younger age group. In men 55 years or younger, 
negative self-image (HR: 1.53; 95% CI 1.06-2.21) and indecisiveness (HR: 1.53; 95% CI 1.15-2.04) were associated 
with all-cause mortality, while fatigue was associated with all-cause mortality in men 70 years or older (HR: 1.45; 95% 
CI 1.20-1.74).
(TABLE 3 HERE)
Two-way interaction terms of mortality
When a potential three-way interaction between an item of the BDI10, age and sex could not be detected, we 
investigated for potential two-way interactions between these remaining BDI10 items and age or sex. We also 
investigated for a potential two-way interaction between BDI10 sum scores and age or sex. Potential two-way 
interactions between BDI10 sum scores and age (HR: 0.99; 0.99 – 1.00; p = .087) and between BDI10 sum scores and 
sex (HR: 1.15; 1.01–1.31; p =. 028) were found. There were also potential two-way interactions between age and the 
following depressive symptoms of the BDI10: hopelessness (HR: 0.99; 0.98 – 1.00, p = .051), sense of failure (HR: 
0.98; 0.97 – 1.00, p = .020) and work difficulties (HR: 0.99; 0.98 – 1.00, p = .139). Potential two-way significant 
interactions between BDI10 and sex were found for sadness (HR: 1.25; 1.01 – 1.54, p = .035) and work difficulties 
(HR: 1.12; 0.94 – 1.33, p = .200).
7Subgroup analyses of mortality according to either age or sex
Age subgroup analyses assessing the risk of all-cause mortality were conducted for the following variables: 
BDI10 sum score, hopelessness, sense of failure, and work difficulties (Table 4). The BDI10 sum score and work 
difficulties were significantly associated with mortality across each of the three age subgroups. Hopelessness was also 
significantly associated with mortality in both the 56-69 year (HR: 1.26) and ≥70 age groups (HR: 1.24), but not those 
aged ≤55 years.
Sex subgroup analyses assessing the risk of all-cause mortality were conducted for the BDI10 sum score, 
sadness, and work difficulties (Table 4). The item “work difficulties” was associated with all-cause mortality in both 
women and men, but the effect was stronger in men (HR: 1.33) than in women (HR: 1.22). Sadness and the total BDI10 
sum score were associated with all-cause mortality in men (HR: 1.24) but not in women (HR: 0.94).
(TABLE 4 HERE)
Sensitivity analyses with adjustment for LVEF
The sensitivity analyses with adjustment for LVEF included five studies, and the sample size was roughly 30% 
smaller than the sample size used in the main analyses. Results of the sensitivity analyses stratified by age and sex 
groups are available in Table 5. In women aged ≤55 years the results were virtually the same as in the models without 
adjustment for LVEF. In men aged ≤55 years the associations of negative self-image e and indecisiveness with 
mortality were no longer statistically significant. In women aged between 56 and 69 years, negative self-image was 
significantly associated with mortality (HR: 1.46). In men aged between 56 and 69 years, dissatisfaction was no longer 
significantly associated with mortality (p = .08). In this subgroup, fatigue also became significantly associated with 
mortality. In women ≥70 years, adjustment for LVEF explained the association between suicidal ideation and mortality 
whereas in men ≥70 years old, both dissatisfaction and fatigue remained significantly associated with mortality.
For the 2-way interactions, the pattern of the associations between individual symptoms of depression and all-
cause mortality was similar to the main analyses without adjustment for LVEF. In patients’ aged ≤55 years, the BDI10 
total symptom score was no longer significantly associated with mortality. Reporting work difficulties was no longer 
significantly associated with mortality in patients aged between 56 and 69 years (p = .07). There were no substantial 
differences in the pattern of the associations across sex subgroups. Results of sensitivity analysis stratified either by sex 
or age are available in Table 6.
(TABLE 5 HERE)
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Sensitivity analyses including adjustment for the remaining depressive symptoms
Results of the sensitivity analyses including statistical adjustment for the remaining depressive symptoms are 
presented in Supplementary material 3 for the symptoms where a three-way interaction with age and sex was flagged, 
and at supplementary material 4 (supplementary material) for the symptoms where a two-way interaction with either 
sex or age was flagged. For the symptoms suicidal ideation, (in women aged 70 years or older) and negative self-image 
(in men aged 55 years or younger), the association became not statistically significant anymore. For symptoms where a 
two-way interaction was flagged, changes in estimates also only changed slightly, however changes in statistical 
significance were more prominent. For the symptoms hopelessness, work difficulties and sadness all the associations 
became not statistically significant in both sex and age subgroups. 
Discussion
This international, multi-level sample derived from an IPD meta-analysis, indicates a substantial degree of 
heterogeneity in the predictive value of self-reported depressive symptoms associated with all-cause mortality across 
age and sex subgroups
Interactions of individual depressive symptoms with age and sex differences in relation to all-cause mortality
Three-way interactions with age and sex in relation to all-cause mortality were flagged for the following 
individual depressive symptoms: suicidal ideation, negative self-image, dissatisfaction, indecisiveness and fatigue. 
Two-way interactions with sex in relation to all-cause mortality were flagged for hopelessness and work 
difficulties. Two-way interactions with age in relation to all-cause mortality were flagged for work difficulties and 
sadness. A two-way interaction with either sex or age in relation to all-cause mortality was also found for the sum score 
of the BDI10.
Individual depressive symptoms and mortality according to age and sex differences
There was no three-way interaction between age, sex and BDI10 sum score in predicting all-cause mortality, 
but there were three-way interactions with specific depressive symptoms. Dissatisfaction, indecisiveness and negative 
self-image were related to mortality in specific age groups in men, while suicidal ideation was related to mortality in 
women.
9Dissatisfaction was associated with all-cause mortality in men aged 56 years or older, but not in women or 
younger men. Dissatisfaction was a common symptom (45% of the total sample) with 9% endorsing the 
moderate/severe category. Bifactor factor analysis of the BDI suggests that dissatisfaction is a somatic/affective 
symptom that is unrelated to a general depression factor, and that it predicts mortality and recurrent cardiac events(de 
Miranda Azevedo et al. 2016). Regardless of being a marker of depression or somatic illness, dissatisfaction is a major 
risk marker in middle-aged and older men. Importantly, interdisciplinary health promotion improves satisfaction in 
older adults(Wilhelmson, Eklund 2013).
Indecisiveness and negative self-image are two symptoms of depression that were associated with an increased 
risk of all-cause mortality in men 55 years or younger. We hypothesize that indecisiveness could predict failure to make 
lifestyle changes in younger patients with MI, since they are more likely to adhere to an unhealthy lifestyle. 
Indecisiveness may also be a marker or determinant of chronic stress in this age group.
Negative self-image has been previously shown to be associated with being overweight in patients with MI 
(Guiry et al. 1987). The possibility of residual confounding as a function of unhealthy lifestyle and medical 
comorbidities cannot be discarded.  
Suicidal ideation was only associated with an increased risk of all-cause mortality in women aged ≥70 years. 
Suicidal ideation may reflect a more severe form of depression and therefore should be addressed by clinicians and 
discussed with their patients. Unfortunately, it was not possible for us to assess whether there was a higher incidence of 
suicide among women aged ≥70 years, since cause of death was not recorded. Moreover, we cannot exclude the 
possibility that this symptom might also be an indicator of mortality in men, as it has been stated that men tend to 
underreport cognitive-affective symptoms of depression such as suicidal ideation (Sigmon et al. 2005). 
Age and sex differences: sensitivity analyses including statistical adjustment for LVEF
In the sensitivity analyses including adjustment for LVEF, the association between dissatisfaction and 
mortality in men aged 56 to 69 years was no longer statistically significant (p = .08). The associations of indecisiveness 
and negative self-image with mortality were also no longer statistically significant in the sensitivity analyses in men 
aged ≤55 years, and the association between suicidal ideation and all-cause mortality in women aged ≥70 years was 
also no longer statistically significant. Although the sensitivity analyses suggest that LVEF may help to explain the 
association between individual symptoms of depression and all-cause mortality in younger men and older women with 
MI, the sample size was substantially reduced (30% and 42%, respectively) because of missing LVEF data. Therefore, 
it could be that statistical power in these subgroups was limited. Nonetheless, markers of heart disease severity such as 
LVEF and Killip class should be routinely included in future studies assessing the association between depressive 
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symptoms and cardiovascular outcomes.
Frequently reported depressive symptoms and mortality
Fatigue (74%) and work difficulties (62%) were the two symptoms most frequently reported. The 3-way 
interaction between fatigue, age and sex indicated that fatigue was significantly associated with all-cause mortality in 
women aged 56-69 years and men ≥70 years. However, the p-values of the association between fatigue and mortality 
in younger women and younger and middle-aged men were close to .05. In sensitivity analyses adjusting for LVEF, the 
association between fatigue and all-cause mortality also became statistically significant for men aged between 56 and 
69 years. Some have suggested that fatigue should be assessed separately from other depressive symptoms in order to 
prevent being missed in low depression sum scores (Alsen et al. 2010). Evidence suggests that fatigue can be decreased 
through moderate aerobic exercise training(Sandor et al. 2014).
Work difficulties revealed significant two-way interactions with age and sex. Yet, in subgroup analyses, work 
difficulties were significantly associated with all-cause mortality in all patients regardless of age and sex.
Symptoms of general depression factor and mortality
For hopelessness and sadness, a potential 2-way interaction with age indicated that hopelessness was 
associated with mortality only in participants that aged ≥56 years. Hopelessness is associated with other risk factors for 
adverse prognosis, such as lower adherence to cardiac rehabilitation and physical inactivity (Valtonen et al. 2009). 
Sadness was significantly associated with an increased risk of all-cause mortality in men, but not in women. It 
has been suggested that assessing sadness through more items could offer advantages, as this symptom is considered to 
be rather complex (Fried, Nesse 2015). 
Clinical implications
To date, it has been reported that psychotherapy and psychopharmacological interventions (i.e. 
antidepressants) have a small but clinically significant effect on decreasing depressive symptomatology in patients with 
CHD (Baumeister, Hutter & Bengel 2014). Overall, receiving anti-depressant treatment did not show to efficiently 
improve medical prognosis in patients with CHD. However, secondary analyses of clinical depression trials in patients 
with CHD suggest that prognosis improves when depression improves (Carney, Freedland 2017). Regardless of 
improving medical prognosis, depressive symptoms should always be treated when necessary, as they provide 
substantial suffering for the individual. Moreover, future studies should assess whether interventions focused on 
treating cognitive symptoms. To our knowledge there are no studies assessing whether solely modifying negative self-
11
image and indecisiveness could be improve medical prognosis in younger men. Findings from a meta-analysis 
suggested that stand-alone cognitive-behavior therapy for self-image significantly improves negative self-image (Jarry, 
Ip 2005). This intervention includes a combination of cognitive restructuring, self-monitoring and psychoeducation 
aimed at dysfunctional cognitions, with the objective to improve exposure, response prevention and desensitization of 
the participant in the way that the individual progressively stops experiencing a negative view of himself or herself. 
Our findings could serve as a framework for future researchers who aim to tailor new symptom-specific interventions. 
Moreover, the predictive models including the complete sample, as opposed to models based on subsamples that 
adjusted for LVEF, may be more generalizable.
Limitations
Findings of the present study should be interpreted in the light of its limitations. Although a previous study 
investigated the validity of the BDI10 (Denollet et al. 2010), the literature on this instrument is scarce. In the present 
study, only the original 21-item BDI was assessed, therefore we had to manually reduce the number of items and the 
response categories in order to compute the BDI10 sum score, which is a limitation of the study.  
Another important limitation of the study was the lack of adjustment for body mass index (BMI). BMI was not 
measured at every study and therefore we did not adjust for it in the predictive models. Moreover, missing data for 
individual symptoms of depression had already been imputed for a large parcel of the sample using mean imputation. 
For this reason, we could not use more sophisticated techniques for addressing missing data. 
We did not formulate a hypothesis prior to assessing the predictive value of individual symptoms of 
depression. This could lead to chance findings due to the problem of multiple testing. Due to the exploratory nature of 
the present study, we did not use any correction for multiple testing, as these could be rather conservative for our 
purposes. Therefore, findings of the present study should be interpreted with care and further replicated before 
definitive conclusions are made.
Conclusions
Findings from the present study suggest that men and women from different age groups are differentially 
affected by symptoms of depression. Although adjustment for LVEF helped to explain the association in younger men 
and older women, adjusting for LVEF did not seem to change the pattern of the associations in middle-aged patients or 
in older men. Future research needs to account for large heterogeneity in the predictive value of individual depressive 
symptoms among post-MI patients.
12
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1Table 1: Individual studies characteristics
First 
author. 
year
Country and 
start baseline 
assessment 
(year)
N Age 
(mean, 
sd)
Male
(%)
History 
of MI 
(%)
Diabe 
tes 
(%)
Smok 
ing 
(%)
LVEF ≤
40%
Median 
and
IQR
Incidence of 
endpoint (%)
Mean follow-
up time 
(years)
Lane, 
2001
United Kingdom, 
1997
288 62.7 
(11.5)
75 22 12 43 N/A Median: 2 
IQR: 3
13 2.7
Berkman, 
2003
USA, 1996 2848 60.8 
(12.3)
58 26 32 31 28 Median: 6 
IQR: 6
12 2.3
Lauzon, 
2003
Canada, 1996 552 60.2 
(12.2)
79 21 16 40 N/A Median: 2 
IQR: 4
6 1.0
Spijkerma
n, 2005
The Netherlands,
1997
499 60.7 
(11.7)
81 14 10 53 23 Median: 2 
IQR: 3
22 7.3
Van 
Melle, 
2007
The Netherlands, 
1999
1814 61.0 
(11.6)
78 13 12 48 25 Median: 2
IQR: 3
15 6.0
Parakh, 
2008
USA, 1995 280 64.9 
(12.1)
57 31 35 29 30 Median: 1 
IQR: 2
54 6.6
2Denollet, 
2010
The Netherlands,
2003
498 59.6 
(11.6)
78 14 14 38 15 Median: 2 
IQR: 3
8 3.8
Combined 
sample
Various 6773 61.0 
(12.0)
69 20 22 39 25 Median: 4 
IQR: 6
15 3.8
*ACM: All-cause mortality; IQR: Inter-quartile range; MI: Myocardial Infarction; N/A: Not applicable.
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1Table 2. Prevalence and internal consistency of depressive symptoms (N= 6,773)
Depression symptom
(BDI10)
Mild (score 1) Moderate -
severe (2)
Item-rest correlation Alpha if item deleted
Sadness 29% 8% 0.583 0.803
Hopelessness 20% 9% 0.608 0.801
Sense of failure 10% 7% 0.519 0.812
Self-dislike 19% 5% 0.568 0.807
Suicidal ideation 6% 1% 0.346 0.827
Negative self-image 12% 6% 0.464 0.816
Dissatisfaction 36% 9% 0.612 0.799
Indecisiveness 20% 11% 0.481 0.814
Work difficulties 39% 23% 0.510 0.811
Fatigue 52% 22% 0.457 0.815
1Table 3. Subgroup analyses of depressive symptoms and mortality according to both age and sex.
≤55 years 56-69 years ≥70 yearsDepressive 
symptom
(BDI10)
Women
N = 539
Men
N = 1,738
Women
N = 721
Men
N = 1,727
Women
N = 701
Men
N = 938
Suicidal
ideation
0.57
(0.16-2.01)
p = .384
1.31
(0.74-2.35)
p = .350
0.94
(0.42-2.06)
p = .702
0.59
(0.28-1.24)
p = .169
1.58   (1.03-
2.43) p = 
.037
1.23
(0.73-2.07)
p = .433
Negative self-image 0.68
(0.40-1.18)
p = .173
1.53
(1.06-2.21)
p = .022
1.31
(0.94-1.81)
p = .108
1.26
(0.94-1.69)
p = .120
1.23
(0.96-1.57)
p = .088
1.23
(0.93-1.63)
p = .144
Dissatisfaction 1.19
(0.75-1.89)
p = .457
1.14
(0.83-1.58)
p = .410
1.30
(0.94-1.80)
p = .109
1.35
(1.07-1.71)
p = .011
1.06
(0.84-1.33)
p = .590
1.34
(1.10-1.63)
p = .003
Indecisiveness 0.87
(0.56-1.38)
p = .567
1.53
(1.15-2.04)
p = .003
0.74
(0.55-1.01)
p =.063
1.14
(0.92-1.42)
p = .222
1.07
(0.88-1.31)
p = .485
1.04
(0.87-1.25)
p = .635
Fatigue 1.49
(0.94-2.35)
p = .087
1.36
(0.97-1.91)
p = .066
1.54
(1.09-2.15)
p = .012
1.21
(0.96-1.52)
p = .105
1.07
(0.86-1.32)
p = .538
1.45
(1.20-1.74)
p < .001
*Significant associations marked in bold (p < .05).
1Table 4. Subgroup analyses of depressive symptoms and mortality according to either age or sex
Age groups Sex
Depressive
symptom
(BDI10)
≤55 years
N = 2,277
56-69 years
N = 2,448
≥70 years
N = 1,639
Women
N = 1,961
Men
N = 4,403
Total symptom
score
1.20
(1.01-1.42);
p=. 040
1.16
(1.02-1.36);
p  = .005
1.25
(1.13-1.38);
p < .001
1.11
(0.99-1.24);
p = .062
1.31
(1.19-1.44);
p < .001
Hopelessness 1.22
(0.95-1.57);
p= .119
1.26
(1.04-1.53);
p  = .017
1.24  
(1.08-1.43); 
p = .002
Work 
difficulties
1.37
(1.09-1.73);
p =. 007
1.25
(1.06-1.48);
p = .007
1.29
(1.14-1.47);
p < .001
1.22
(1.05-1.42);
p = .009
1.33
(1.19-1.50);
p < .001
Sadness 0.94
(0.79-1.11);
p = .486
1.24
(1.07-1.30);
p = .004
*Significant associations marked in bold (p < .05). 
1Table 5. Sensitivity subgroup analyses of depressive symptoms and mortality according to both age and sex 
including adjustment for LVEF ≤ 40% (three-way interactions)
≤55 years 56-69 years ≥70 yearsDepressive
symptom
(BDI10)
Women
N = 394
Men
N = 1210
Women
N = 502
Men
N = 1252
Women
N = 467
Men
N = 685
Suicidal
ideation
0.62
(0.17-2.28)
p = .476
1.07
(0.49-2.31)
p = .863
1.19
(0.56-2.51)
p = .653
0.43
(0.18-1.02)
p = .057
1.45
(0.84-2.51)
p = .185
1.32
(0.77-2.28)
p = .339
Negative self-
image
0.84
(0.46-1.54)
p = .577
1.44
(0.92-2.26)
p = .111
1.46
(1.00-2.09)
p = .047
1.24
(0.90-1.70)
p = .184
1.29
(0.97-1.71)
p = .083
1.32
(0.98-1.77)
p = .067
Dissatisfaction 1.03
(0.57-1.86)
p = .914
0.98
(0.67-1.43)
p = .927
1.22
(0.85-1.74)
p = .282
1.26
(0.97-1.65)
p = .085
1.02
(0.77-1.36)
p = .861
1.46
(1.15-1.86)
p = .002
Indecisiveness 0.93
(0.55-1.55)
p = .787
1.29
(0.91-1.83)
p = .152
0.77
(0.55-1.08)
p = .126
1.24
(0.98-1.56)
p = .063
1.05
(0.82-1.35)
p = .669
1.09
(0.89-1.35)
p = .376
Fatigue 1.47
(0.88-2.48)
p = .139
1.12
(0.77-1.63)
p = .548
1.48
(1.04-2.12)
p = .031
1.31
(1.01-1.69)
p = .039
1.19
(0.92-1.55)
p = .186
1.45
(1.18-1.78)
p = .001
*Significant associations marked in bold (p < .05).
1Table 6. Subgroup analyses of depressive symptoms and mortality according to either age or sex 
including adjustment for LVEF ≤ 40%(two-way interactions)
Age groups Sex
Depressive
symptom
(BDI10)
≤55 years
N = 1,604
56-69 years
N = 1,754
≥70 years
N = 1,152
Women
N = 1,363
Men
N = 3,147
Total symptom
score
1.07 
(0.87-1.33);
p = .503
1.16
 (1.01-1.33);
p  = .033
1.31 
(1.17-1.48);
p < .001
1.12 
(0.98-1.28);
p = .108
1.29 
(1.16-1.44);
p < .001
Hopelessness 1.01
 (0.73-1.39);
p = .954
1.26 
(1.02–1.56);
p  = .035
1.31 
(1.11-1.54);
p = .001
Work difficulties 1.37
 (1.05-1.77);
p  = .017
1.18 
(0.99-1.42);
p = .070
1.27
(1.10-1.47);
p = .001
1.21
 (1.02-1.44);
p = .029
1.29
 (1.13-1.47);
p < .001
Sadness 0.91 
(0.74-1.12);
p = .389
1.24 
(1.05-1.45);
p < .001
*Significant associations marked in bold (p < .05).
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1Supplementary material 1. Univariable models of clinical covariates predicting all-cause mortality
Clinical covariate Risk
(HR; 95% CI), p- valueHistory of MI 2.60 (2.27 – 2.96); p < .001
Aspirin use 0.46 (0.40 – 0.54); p < .001
Beta-blocker use 0.54 (0.47 – 0.62);p < .001
Smoking 0.63 (0.55 – 0.73);p < .001
Diabetes 2.32 (2.02 – 2.65);p < .001
1Supplementary material 2. Three-way interaction models
Item Interaction term
(HR; 95% CI), p- valueSadness X Sex X Age 1.00 (0.98 – 1.02); P = .625
Hopelessness X Sex X Age 1.01 (0.99 – 1.03); P = .384
Sense of failure X Sex X Age 0.99 (0.97 – 1.01); P = .406
Self-dislike X Sex X Age 0.99 (0.98 – 1.02); P = .996
Suicidal ideation X Sex X Age2 1.00 (0.99 – 1.00); P = .065
Negative self-image X Sex X Age 0.98 (0.96 – 1.00);  P = .127
Dissatisfaction X Sex X Age 1.01 (0.99 – 1.03);  P = .170
Indecisiveness X Sex X Age 0.99 (0.97 – 1.00); P = .145
Work difficulties X Sex X Age 0.99 (0.98 – 1.01); P = .683
Fatigue X Sex X Age 1.02 (1.00 – 1.04); P = .020
*Potentially relevant interactions are marked in bold; following previous recommendations, a 
confidence level of .20 was used when screening for interactions. 
1Supplementary material 3. Subgroup analyses of depressive symptoms and mortality according to both age 
and sex, including statistical adjustment for the remaining individual symptoms of depression.
≤55 years 56-69 years ≥70 yearsDepressive 
symptom
(BDI10)
Women
N = 539
Men
N = 1,738
Women
N = 721
Men
N = 1,727
Women
N = 701
Men
N = 938
Suicidal
ideation
0.72
(0.19-2.70)
p = .628
0.98
(0.52-1.84)
p = .954
0.89
(0.39-2.03)
p = .791
0.47
(0.22-0.99)
p = .047
1.48 
(0.94-2.32) 
p = .089
1.06
(0.62-1.82)
p = .825
Negative self-image 0.65
(0.37-1.14)
p = .134
1.31
(0.87-1.96)
p = .192
1.33
(0.93-1.89)
p = .116
1.19
(0.93-1.89)
p = .116
1.18
(0.91-1.52)
p = .199
1.13
(0.85-1.52)
p = .390
Dissatisfaction 1.13
(0.66-1.92)
p = .659
0.85
(0.58-1.25)
p = .404
1.29
(0.90-1.86)
p = .169
1.31
(1.00-1.71)
p = .046
0.98
(0.76-1.25)
p = .865
1.25
(1.01-1.54)
p = .033
Indecisiveness 0.81
(0.49-1.32)
p = .395
1.44
(1.02-2.03)
p = .036
0.58
(0.41-0.82)
p =.002
1.03
(0.81-1.31)
p = .798
1.01
(0.82-1.26)
p = .892
0.87
(0.71-1.06)
p = .162
Fatigue 1.69
(0.99-2.88)
p = .056
1.23
(0.85-1.77)
p = .270
1.66
(1.15-2.40)
p = .007
1.12
(0.87-1.44)
p = .353
1.03
(0.82-1.30)
p = .766
1.43
(1.17-1.74)
p < .001
*Significant associations marked in bold (p < .05).
1Supplementary material 4. Subgroup analyses of depressive symptoms and mortality according to either age 
or sex, including statistical adjustment for the remaining individual symptoms of depression.
Age groups Sex
Depressive
symptom
(BDI10)
≤55 years
N = 2,277
56-69 years
N = 2,448
≥70 years
N = 1,639
Women
N = 1,961
Men
N = 4,403
Hopelessness 1.18
(0.85-1.66)
p= .313
1.24
(0.97-1.57)
p  = .092
1.14  
(0.95-1.35)
p = .147
Work 
difficulties
1.27
(1.94-1.70)
p = . 118
1.18
(1.96-1.46)
p = .111
1.15
(0.99-1.35)
p = .070
1.17
(0.97-1.41)
p = .091
1.15
(0.99-1.33)
p = .061
Sadness 0.81
(0.67-0.98)
p = .036
1.02
(1.86-1.21)
p = .814
*Significant associations marked in bold (p < .05). 
